Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrew Peter Selwyn, M.D., M.B.Ch.B.

Co-Author

This page shows the publications co-authored by Andrew Selwyn and Scott Kinlay.
Connection Strength

1.515
  1. Effects of statins on inflammation in patients with acute and chronic coronary syndromes. Am J Cardiol. 2003 Feb 20; 91(4A):9B-13B.
    View in: PubMed
    Score: 0.265
  2. Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics. Am Heart J. 2004 May; 147(5):875-82.
    View in: PubMed
    Score: 0.072
  3. Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol. 2004 Feb 18; 43(4):629-34.
    View in: PubMed
    Score: 0.071
  4. Coronary flow velocity and disturbed flow predict adverse clinical outcome after coronary angioplasty. Arterioscler Thromb Vasc Biol. 2002 Aug 01; 22(8):1334-40.
    View in: PubMed
    Score: 0.064
  5. Clopidogrel inhibits shear-induced platelet function. Platelets. 2002 May; 13(3):187-9.
    View in: PubMed
    Score: 0.063
  6. Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension. 2001 Nov; 38(5):1049-53.
    View in: PubMed
    Score: 0.060
  7. Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries. Circulation. 2001 Sep 04; 104(10):1114-8.
    View in: PubMed
    Score: 0.060
  8. Usefulness of intravascular ultrasound in preventing stenting of hazy areas adjacent to coronary stents and its support of support spot-stenting. Am J Cardiol. 2001 Jun 01; 87(11):1246-9.
    View in: PubMed
    Score: 0.059
  9. Manipulating the vascular biology of coronary atherosclerosis in diabetes: new opportunities. J Lab Clin Med. 2001 Feb; 137(2):82-92.
    View in: PubMed
    Score: 0.057
  10. Lack of compensatory enlargement at sites of coronary vasospasm: identification by ultrasound and successful treatment with stenting. Clin Cardiol. 2000 Nov; 23(11):865-8.
    View in: PubMed
    Score: 0.056
  11. Lipid-lowering therapy after coronary revascularization. Am J Cardiol. 2000 Aug 24; 86(4B):18H-28H.
    View in: PubMed
    Score: 0.056
  12. Treating ambulatory ischemia in coronary disease by manipulating the cell biology of atherosclerosis. Curr Atheroscler Rep. 2000 Jul; 2(4):321-6.
    View in: PubMed
    Score: 0.055
  13. Pathophysiology of atherosclerosis: development, regression, restenosis. Curr Atheroscler Rep. 2000 May; 2(3):251-8.
    View in: PubMed
    Score: 0.054
  14. Atherogenic lipids and endothelial dysfunction: mechanisms in the genesis of ischemic syndromes. Annu Rev Med. 2000; 51:149-67.
    View in: PubMed
    Score: 0.053
  15. Plasma alpha-tocopherol and coronary endothelium-dependent vasodilator function. Circulation. 1999 Jul 20; 100(3):219-21.
    View in: PubMed
    Score: 0.052
  16. Inflammation, the endothelium, and the acute coronary syndromes. J Cardiovasc Pharmacol. 1998; 32 Suppl 3:S62-6.
    View in: PubMed
    Score: 0.046
  17. Atherogenesis and ischemic heart disease. Am J Cardiol. 1997 Oct 30; 80(8B):3H-7H.
    View in: PubMed
    Score: 0.046
  18. Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease. Am J Cardiol. 1997 Mar 06; 79(5A):17-23.
    View in: PubMed
    Score: 0.044
  19. Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease. Circulation. 1997 Jan 07; 95(1):5-7.
    View in: PubMed
    Score: 0.043
  20. Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points. Curr Opin Lipidol. 1996 Dec; 7(6):389-97.
    View in: PubMed
    Score: 0.043
  21. Endothelin-1 is a key mediator of coronary vasoconstriction in patients with transplant coronary arteriosclerosis. Circ Heart Fail. 2009 Sep; 2(5):409-16.
    View in: PubMed
    Score: 0.026
  22. Improved characterization of atherosclerotic plaques by gadolinium contrast during intravascular magnetic resonance imaging of human arteries. Atherosclerosis. 2008 Feb; 196(2):919-25.
    View in: PubMed
    Score: 0.022
  23. Impact of coronary endothelial function on the progression of cardiac transplant-associated arteriosclerosis: effect of anti-oxidant vitamins C and E. J Heart Lung Transplant. 2006 Apr; 25(4):426-33.
    View in: PubMed
    Score: 0.021
  24. Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging. Circulation. 2005 Oct 11; 112(15):2324-31.
    View in: PubMed
    Score: 0.020
  25. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study. Circulation. 2005 Apr 12; 111(14):1747-55.
    View in: PubMed
    Score: 0.019
  26. Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation. Arterioscler Thromb Vasc Biol. 2002 Dec 01; 22(12):2044-8.
    View in: PubMed
    Score: 0.016
  27. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet. 2002 Mar 30; 359(9312):1108-13.
    View in: PubMed
    Score: 0.016
  28. Thoughts on the role of the healing professions and the events of September 11, 2001. Circulation. 2002 Mar 26; 105(12):1509-10.
    View in: PubMed
    Score: 0.016
  29. Use of the thrombolysis in myocardial infarction frame count for the quantitative assessment of transplant-associated arteriosclerosis. Am J Cardiol. 2000 Oct 15; 86(8):890-2.
    View in: PubMed
    Score: 0.014
  30. Relation of preservation of nitric oxide-dependent coronary vasomotor function to plasma vitamin C concentrations in cardiac transplant recipients. Am J Cardiol. 2000 Aug 15; 86(4):460-2.
    View in: PubMed
    Score: 0.014
  31. Lipid lowering improves endothelial functions. Int J Cardiol. 2000 Jun 30; 74 Suppl 1:S3-S10.
    View in: PubMed
    Score: 0.014
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.